Logo image of LFVN

LIFEVANTAGE CORP (LFVN) Stock Fundamental Analysis

NASDAQ:LFVN - Nasdaq - US53222K2050 - Common Stock - Currency: USD

18.99  -3.75 (-16.49%)

After market: 19.01 +0.02 (+0.11%)

Fundamental Rating

6

Overall LFVN gets a fundamental rating of 6 out of 10. We evaluated LFVN against 37 industry peers in the Personal Care Products industry. LFVN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. LFVN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year LFVN was profitable.
LFVN had a positive operating cash flow in the past year.
Each year in the past 5 years LFVN has been profitable.
In the past 5 years LFVN always reported a positive cash flow from operatings.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.73%, LFVN is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
LFVN has a Return On Equity of 14.93%. This is amongst the best in the industry. LFVN outperforms 83.33% of its industry peers.
With a decent Return On Invested Capital value of 10.16%, LFVN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LFVN is significantly below the industry average of 13.52%.
The 3 year average ROIC (8.14%) for LFVN is below the current ROIC(10.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.73%
ROE 14.93%
ROIC 10.16%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150 200

1.3 Margins

With a Profit Margin value of 2.11%, LFVN perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
LFVN's Profit Margin has declined in the last couple of years.
The Operating Margin of LFVN (3.14%) is comparable to the rest of the industry.
LFVN's Operating Margin has declined in the last couple of years.
LFVN's Gross Margin of 79.21% is amongst the best of the industry. LFVN outperforms 97.22% of its industry peers.
In the last couple of years the Gross Margin of LFVN has remained more or less at the same level.
Industry RankSector Rank
OM 3.14%
PM (TTM) 2.11%
GM 79.21%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

LFVN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
LFVN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LFVN has less shares outstanding
There is no outstanding debt for LFVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

LFVN has an Altman-Z score of 6.44. This indicates that LFVN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.44, LFVN is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.44
ROIC/WACC1.12
WACC9.07%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.76 indicates that LFVN should not have too much problems paying its short term obligations.
LFVN has a Current ratio (1.76) which is in line with its industry peers.
LFVN has a Quick Ratio of 1.76. This is a bad value and indicates that LFVN is not financially healthy enough and could expect problems in meeting its short term obligations.
LFVN has a Quick ratio of 0.99. This is comparable to the rest of the industry: LFVN outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 0.99
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.00% over the past year.
The Earnings Per Share has been decreasing by -6.69% on average over the past years.
The Revenue has decreased by -6.20% in the past year.
The Revenue has been decreasing by -2.40% on average over the past years.
EPS 1Y (TTM)50%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%120%
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%31.26%

3.2 Future

LFVN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.03% yearly.
The Revenue is expected to grow by 11.83% on average over the next years. This is quite good.
EPS Next Y33.66%
EPS Next 2Y35.02%
EPS Next 3Y35.03%
EPS Next 5YN/A
Revenue Next Year17.95%
Revenue Next 2Y13.12%
Revenue Next 3Y11.83%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.38 indicates a quite expensive valuation of LFVN.
Compared to the rest of the industry, the Price/Earnings ratio of LFVN is on the same level as its industry peers.
LFVN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.37, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 17.96 indicates a rather expensive valuation of LFVN.
Based on the Price/Forward Earnings ratio, LFVN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
LFVN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 96.21.
Industry RankSector Rank
PE 26.38
Fwd PE 17.96
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as LFVN.
The rest of the industry has a similar Price/Free Cash Flow ratio as LFVN.
Industry RankSector Rank
P/FCF 44.23
EV/EBITDA 28.13
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

LFVN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of LFVN may justify a higher PE ratio.
LFVN's earnings are expected to grow with 35.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y35.02%
EPS Next 3Y35.03%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.67%, LFVN is not a good candidate for dividend investing.
LFVN's Dividend Yield is a higher than the industry average which is at 4.90.
With a Dividend Yield of 0.67, LFVN pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.67%

5.2 History

LFVN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

LFVN pays out 46.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP46.2%
EPS Next 2Y35.02%
EPS Next 3Y35.03%
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LIFEVANTAGE CORP

NASDAQ:LFVN (2/6/2025, 5:20:02 PM)

After market: 19.01 +0.02 (+0.11%)

18.99

-3.75 (-16.49%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)N/A N/A
Inst Owners30.47%
Inst Owner Change0.38%
Ins Owners16.35%
Ins Owner Change2.66%
Market Cap237.94M
Analysts82.5
Price Target33.15 (74.57%)
Short Float %1.87%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield 0.67%
Yearly Dividend0.55
Dividend Growth(5Y)N/A
DP46.2%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.3%
Min EPS beat(2)-34.64%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)34.29%
Min EPS beat(4)-34.64%
Max EPS beat(4)145.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.45%
Min Revenue beat(2)-7.05%
Max Revenue beat(2)-5.85%
Revenue beat(4)0
Avg Revenue beat(4)-7.41%
Min Revenue beat(4)-9.36%
Max Revenue beat(4)-5.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25%
PT rev (3m)364.29%
EPS NQ rev (1m)-4.76%
EPS NQ rev (3m)2.56%
EPS NY rev (1m)1.33%
EPS NY rev (3m)5.56%
Revenue NQ rev (1m)29.85%
Revenue NQ rev (3m)28.45%
Revenue NY rev (1m)16.44%
Revenue NY rev (3m)16.44%
Valuation
Industry RankSector Rank
PE 26.38
Fwd PE 17.96
P/S 1.21
P/FCF 44.23
P/OCF 34.77
P/B 8.59
P/tB 8.68
EV/EBITDA 28.13
EPS(TTM)0.72
EY3.79%
EPS(NY)1.06
Fwd EY5.57%
FCF(TTM)0.43
FCFY2.26%
OCF(TTM)0.55
OCFY2.88%
SpS15.64
BVpS2.21
TBVpS2.19
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.73%
ROE 14.93%
ROCE 15.62%
ROIC 10.16%
ROICexc 16.13%
ROICexgc 16.33%
OM 3.14%
PM (TTM) 2.11%
GM 79.21%
FCFM 2.74%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
ROICexc(3y)14.83%
ROICexc(5y)33.63%
ROICexgc(3y)15.14%
ROICexgc(5y)35.34%
ROCE(3y)12.51%
ROCE(5y)23.24%
ROICexcg growth 3Y-29.46%
ROICexcg growth 5Y-27.73%
ROICexc growth 3Y-29.25%
ROICexc growth 5Y-26.49%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
F-Score7
Asset Turnover3.19
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 42.34%
Cap/Sales 0.75%
Interest Coverage 250
Cash Conversion 71.21%
Profit Quality 130.14%
Current Ratio 1.76
Quick Ratio 0.99
Altman-Z 6.44
F-Score7
WACC9.07%
ROIC/WACC1.12
Cap/Depr(3y)65.13%
Cap/Depr(5y)79.97%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.23%
Profit Quality(3y)232.22%
Profit Quality(5y)185.98%
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%120%
EPS Next Y33.66%
EPS Next 2Y35.02%
EPS Next 3Y35.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%31.26%
Revenue Next Year17.95%
Revenue Next 2Y13.12%
Revenue Next 3Y11.83%
Revenue Next 5YN/A
EBIT growth 1Y65.4%
EBIT growth 3Y-37.33%
EBIT growth 5Y-15.06%
EBIT Next Year89.76%
EBIT Next 3Y42.02%
EBIT Next 5YN/A
FCF growth 1Y26.29%
FCF growth 3Y-7.39%
FCF growth 5Y-8.22%
OCF growth 1Y11.47%
OCF growth 3Y-9.16%
OCF growth 5Y-7.27%